Machine generated authority record.

Work cat.: (ESSALUD): Jackisch, Christian Autor 13936, HannaH phase III randomised study: association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant-adjuvant trastuzumab after 2 years of treatment-free follow-up.